| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 390 |
| 1 | DEXAMETHASONE | 363 |
| 2 | DEXAMETHASONE 1.5 MG | 362 |
| 3 | METHOTREXATE | 344 |
| 4 | CYCLOPHOSPHAMIDE | 338 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 338 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 338 |
| 7 | PREDNISONE | 323 |
| 8 | CYTARABINE | 298 |
| 9 | METHYLPREDNISOLONE | 264 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICHTHAMMOL OINTMENT | 2 | 0.0526 |
| 1 | PEGFILGRASTIM-BMEZ | 26 | 0.0428 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 58 | 0.0352 |
| 3 | DROPERIDOL | 42 | 0.0250 |
| 4 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 5 | PEGASPARGASE | 220 | 0.0178 |
| 6 | LEVAMLODIPINE | 2 | 0.0160 |
| 7 | DEXRAZOXANE FOR INJECTION | 14 | 0.0148 |
| 8 | MESNA INJECTION | 115 | 0.0138 |
| 9 | CETYLPYRIDINIUM CHLORIDE | 9 | 0.0138 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 708 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 420 |
| 2 | Alkylating Drug [EPC] | 401 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 348 |
| 4 | Leukocyte Growth Factor [EPC] | 275 |
| 5 | Topoisomerase Inhibitor [EPC] | 250 |
| 6 | Asparagine-specific Enzyme [EPC] | 220 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 200 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 163 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 155 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Asparagine-specific Enzyme [EPC] | 220 | 0.0163 |
| 2 | CD123 Interaction [EPC] | 7 | 0.0130 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 46 | 0.0059 |
| 4 | Cannabinoid [EPC] | 36 | 0.0044 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 36 | 0.0041 |
| 6 | Echinocandin Antifungal [EPC] | 33 | 0.0040 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 15 | 0.0039 |
| 8 | CD33-directed Immunoconjugate [EPC] | 14 | 0.0038 |
| 9 | Topoisomerase Inhibitor [EPC] | 250 | 0.0032 |